β-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon

Diabetes Care

Volumn 27, Issue 10, 2004, Pages 2405-2408

  Valerio, Giuliana ^a,f   Franzese, Adriana ^b   Salerno, Mariacarolina ^b   Muzzi, Gianluca ^c   Cecere, Gaetano ^c   Temple, Karen I ^d   Shield, Julian P ^e  

^a UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Magna Grecia University   (Italy)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f Faculty of Movement Sciences   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; PROTEIN G;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CELL FUNCTION; CHILD; CHROMOSOME 6; CHROMOSOME DUPLICATION; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET; DIET RESTRICTION; FEMALE; HORMONE RESPONSE; HUMAN; HYPERGLYCEMIA; INFANT; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LONG TERM CARE; MALE; MICROANGIOPATHY; NEWBORN; NEWBORN DISEASE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PUBERTY; RELAPSE; TREATMENT FAILURE; UNIPARENTAL DISOMY;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 6; DIABETES MELLITUS; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; PEDIGREE; RARE DISEASES; REMISSION, SPONTANEOUS; RISK ASSESSMENT; SAMPLING STUDIES; SIBLINGS;

EID: 4644256595     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.10.2405     Document Type: Article

References (24)

1. Shield JP: Neonatal diabetes: new insights into aetiology and implications. Horm Res 53 (Suppl. 1):7-11, 2000
2. Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP: Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes, Diabetes 49:1359-1366, 2000
3. Hermann R, Laine A-P, Johansson C, Niederland T, Tokarska L, Dziatkowiak H, Ilonen J, Soltész G: Transient but not permanent neonatal diabetes mellitus is associated with paternal uniparental isodisomy of chromosome 6. Pediatrics 105: 49-52, 2000
4. Metz C, Cavé H, Bertrand AM, Deffert C, Gueguen-Giroux B, Czernichow P, Polak M, NDM French Study Group: Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J Pediatr 141:483-489, 2002
5. Marquis E, Robert JJ, Bouvattier C, Bellanné-Chantelot C, Junien C, Diatloff-Zito C: Major difference in aetiology and phenotypic abnormalities between transient and permanent neonatal diabetes. J Med Genet 39:370-374, 2000
6. Gardner RJ, Robinson DO, Lamont L, Shield JP, Temple IK: Paternal uniparental disomy of chromosome 6 and transient neonatal diabetes mellitus. Clin Genet 54: 522-525, 1998
7. Gardner RJ, Mungall AJ, Dunham I, Barber JC, Shield JP, Temple IK, Robinson DO: Localisation of a gene for transient neonatal diabetes mellitus to an 18.72 cR(3000) (∼5.4 Mb) interval on chromosome 6q. J Med Genet 36:192-196, 1999
8. Gardner RJ, Mackay DJG, Mungall AJ, Polychronakos C, Siebert R, Shield JPH, Temple IK, Robinson DO: An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet 9:589-596, 2000
9. Temple IK, Shield JP: Transient neonatal diabetes, a disorder of imprinting. J Med Genet 39:872-875, 2002
10. Arima T, Drewell RA, Arney KL, Inoue J, Makita Y, Hata A, Oshimura M, Wake N, Surani MA: A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus. Hum Molec Genet 10:1475-1483, 2001
11. Temple IK, Gardner RJ, Robinson DO, Kibirige MS, Ferguson AW, Baum JD, Barber JC, James RS, Shield JP: Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Hum Mol Genet 5:1117-1124, 1996
12. Cavé H, Polak M, Drunat S, Denamur E, Czernichow P: Refinement of the 6q chromosomal region implicated in transient neonatal diabetes. Diabetes 49:108-113, 2000
13. Shield JP, Temple IK, Sabin M, Mackay D, Robinson D, Betts P, Carson D, Cavé H, Chevenne D, Polak M: An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission. Arch Dis Child Fetal Neonatal Ed 89:F341-F343, 2004
14. Von Muhlendahl KE, Herkenhoff H: Long-term course of neonatal diabetes. N Engl J Med 333:704-708, 1995
15. Salerno M, Gasparini N, Sandomenico ML, Franzese A, Tenore A: Two interesting cases of transient neonatal diabetes mellitus. J Pediatr Endocrinol Metab 7:47-52, 1994
16. Valeric G, Franzese A, Palmieri A, Mackay DJ, Gardner RJ, Temple IK: Central precocious puberty in a girl with triple X syndrome and neonatal diabetes mellitus associated with paternal isodisomy of chromosome 6. J Pediatr Endocrinol Metab 14:897-900, 2001
17. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA: Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 25:2081-2087, 2002
18. Lorini R, Vanelli M, Prediabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology (SIEDP): Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents. J Ped Endocrinol Metab 9:163-167, 1996
19. Faber OK, Binder C: C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus. Diabetes 26: 605-610, 1977
20. Tanner JM, Goldstein H, Whitehouse RH: Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 47:755-762, 1970
21. Cook JS, Hoffman RP, Stene MA, Hansen JR: Effects of maturational stage of insulin sensitivity during puberty. J Clin Endocrinol Metab 77:725-730, 1993
22. Shield JP, Baum JD: Transient neonatal diabetes and later onset diabetes: a case of inherited insulin resistance. Arch Dis Child 72:56-57, 1995
23. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F: Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261, 1996
24. Holz GG, Chepurny OG: Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus. Curr Med Chem 10: 2471-2483, 2003